EYE ON CHINA
Abstract
Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016
Synthace Awarded Technology Pioneer by World Economic Forum
GSK Institute for Infectious Diseases and Public Health to Partner with Tsinghua University to Tackle Global Public Health Challenges
Fangyuan Pharmaceutical Invests Heavily in R&D of New Drugs for Treatment of Superbacteria
Research Centers to Boost New Zealand-China Science Collaboration
Dehaier Medical Systems Ltd. Cooperates with China Sciences Group (Holding) Co., Ltd. to Enter China's Elderly Sleep Apnea Market
Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Positive Animal Results of Vaccine against Ebola Virus
Ally Bridge Group (ABG) Expands Personalized Medicine Portfolio, Invests in LinkDoc Technology Limited, China's Oncology Big Data Company
Infinitus Establishes International Research Center to Promote Research into the Safety of Chinese Herbal Medicines
Local Scientists Invent Novel DNA Testing Technology to Raise Test Accuracy
Butterflies Offer Climate Scientists Ecological Insights
- Biosimilars
- Pfizer
- global biotechnology center
- China
- investment
- R&D
- HEDA
- diabetes prevention and rehabilitation
- public health
- stevia
- bioscience
- technology
- pioneer
- infectious diseases
- health challenges
- GSK
- public-private partnership
- superbacteria
- treatment
- drugs
- antibiotics
- New Zealand-China Research Collaboration Centers
- sleep apnea
- elderly
- vaccine
- positive animal results
- Ebola virus
- PIKA adjuvant
- big data
- personalized medicine
- cancer
- oncology database
- LinkDoc
- global healthcare
- Chinese herbal medicines
- DNA testing technology
- PCR
- butterfly
- climate
- biological indicators
- environment
